Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe ARDS

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This phase IIb, randomized, placebo‐controlled, double‐blind, dose escalation study will assess the local and systemic safety of 7 days orally inhaled sequential multiple ascending doses of solnatide in patients with pulmonary permeability oedema and moderate‐to‐severe ARDS and review potential efficacy endpoints for a future phase III pivotal trial.
Epistemonikos ID: 2f1caa364b694dd293356ba9a06da947029df5e0
First added on: May 21, 2024